Literature DB >> 8227350

Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.

B Barut1, D Chauhan, H Uchiyama, K C Anderson.   

Abstract

The role of interleukin-6 (IL-6) in the growth of B cell derived hairy cell leukemia (HCL) was characterized. Purified hairy cells (HCs) did not increase DNA synthesis in vitro in response to exogenous IL-6; however, they expressed IL-6 receptor (IL-6R) mRNA and bound directly fluorochrome labeled IL-6. IL-6 mRNA was not detectable in tumor cells by Northern blotting, but was evident using PCR amplification. Although intracytoplasmic IL-6 protein was not demonstrable, HCs did secrete low levels of IL-6. Neutralizing antibody to IL-6 did not inhibit HC DNA synthesis. Since tumor necrosis factor (TNF) is a growth factor for HCL, we determined whether the TNF effect could be IL-6-mediated. TNF markedly augmented in vitro DNA synthesis by HCs. TNF did not alter IL-6R expression or IL-6 binding; however, IL-6 mRNA and IL-6 protein were detectable after 3-d culture of HCs with TNF. In addition, IL-6 secretion by HCs was markedly augmented by TNF. Finally, although neither IL-6 nor anti-IL-6 antibody altered TNF-induced DNA synthesis by HCs, IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion by HCs. Therefore, IL-6 does not directly affect the growth of HCL, but rather mediates TNF-induced DNA synthesis via an intracytoplasmic mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227350      PMCID: PMC288416          DOI: 10.1172/JCI116839

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

Authors:  B Klein; X G Zhang; M Jourdan; J Content; F Houssiau; L Aarden; M Piechaczyk; R Bataille
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

2.  Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia.

Authors:  A Biondi; V Rossi; R Bassan; T Barbui; S Bettoni; M Sironi; A Mantovani; A Rambaldi
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

3.  Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer.

Authors:  T M Browder; J S Abrams; P M Wong; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

4.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

Authors:  K Yamasaki; T Taga; Y Hirata; H Yawata; Y Kawanishi; B Seed; T Taniguchi; T Hirano; T Kishimoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

5.  High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia.

Authors:  A Lindemann; W D Ludwig; W Oster; R Mertelsmann; F Herrmann
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

Review 6.  Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.

Authors:  S Vedantham; H Gamliel; H M Golomb
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

7.  Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2.

Authors:  N Jackson; J Lowe; J Ball; E Bromidge; N R Ling; S Larkins; M J Griffith; I M Franklin
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

8.  Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors:  F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

9.  Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.

Authors:  A A Ghaderi; P Richardson; C Cardona; M J Millsum; N Ling; S Gillis; J Ledbetter; J Gordon
Journal:  Leukemia       Date:  1988-03       Impact factor: 11.528

10.  Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

Authors:  S Shimizu; R Yoshioka; Y Hirose; S Sugai; J Tachibana; S Konda
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  5 in total

1.  Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs.

Authors:  B P Haines; R B Voyle; P D Rathjen
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

Review 2.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

3.  Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

Authors:  M Roth; M Nauck; M Tamm; A P Perruchoud; R Ziesche; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  The ubiquitous interleukin-6: a time for reappraisal.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2010-10-11       Impact factor: 9.951

5.  Hairy cell leukemia presenting with progressive pericarditis and pleuritis.

Authors:  Atsushi Iwashige; Makoto Hirosawa; Junichi Tsukada
Journal:  Ann Hematol       Date:  2018-05-30       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.